Key facts
- Max Hodak, co-founder of Neuralink and founder of Science Corporation, will speak at TechCrunch Disrupt 2026.
- Hodak will argue that brain-computer interfaces will replace the current screen-based era of technology.
- Science Corporation's PRIMA implant has restored vision for individuals with severe sight loss.
- Science Corporation has raised $230 million in a Series C funding round, valuing the company at $1.5 billion.
- The company is exploring applications for brain-implanted sensors to aid with cognition, mobility, and neurological conditions like Parkinson's disease.
Max Hodak, a co-founder of Neuralink and the founder of Science Corporation, is set to speak at TechCrunch Disrupt 2026, where he will present his vision for a post-screen technological future driven by brain-computer interfaces. Hodak, who previously worked in a brain-computer interface lab at Duke University and co-founded the robotic cloud laboratory Transcriptic, established Science Corporation in 2021 to advance neural engineering and BCI technology.
Science Corporation's PRIMA implant has demonstrated success in restoring vision for individuals with severe vision loss by using a camera-equipped pair of glasses to transmit images to a chip implanted in the retina. The company has secured $230 million in a Series C funding round, achieving a valuation of $1.5 billion. Beyond vision restoration, Hodak envisions the company's implanted sensors aiding cognitive and mobility functions, and potentially treating conditions such as Parkinson's disease and warning about seizures.
TechCrunch Disrupt 2026 will take place at Moscone West in San Francisco from October 13-15, gathering over 10,000 founders, investors, and startup community members. The event will feature a strong focus on sustainable AI companies, with programming across six industry stages.